抗PLA2R1 IgG介导足细胞PLA2R1裂解驱动膜性肾病上皮下免疫复合物沉积
本研究探讨膜性肾病中抗PLA2R1 IgG如何将足细胞抗原转化为基底膜锚定的免疫复合物。体外实验表明,抗PLA2R1 IgG通过ADAM10/17促进足细胞PLA2R1胞外域脱落,脱落片段与IV型胶原/层粘连蛋白结合并捕获IgG;肾活检证实PLA2R1胞外域富集于基底膜沉积物,而胞内域仍局限于足细胞。
要点
- 抗PLA2R1 IgG通过ADAM10/17加速足细胞PLA2R1胞外域脱落
- 脱落胞外域与基底膜成分结合并原位捕获抗PLA2R1 IgG
- 肾活检显示PLA2R1胞外域富集于上皮下沉积物,胞内域仍局限于足细胞
核心结论
- 抗PLA2R1 IgG加速ADAM10/17依赖的足细胞PLA2R1脱落,释放的胞外域锚定于基底膜成分。
- 该机制解释了血清抗体与肾小球抗原匹配及沉积物优先定位于上皮下的现象。
研究设计与样本
- 体外使用稳定表达PLA2R1的人足细胞和表达全长或抗体结合缺陷型PLA2R1(ΔN1-9)的HEK293细胞。
- 刺激物包括PLA2R1阳性膜性肾病血清或纯化IgG、金属蛋白酶激活剂PMA。
- 使用药理学抑制剂测试金属蛋白酶/γ分泌酶依赖性,并设特异性对照。
- 肾活检组织进行双重免疫荧光和双重标记免疫金电镜。
- 体外检测重组胞外域与IV型胶原/层粘连蛋白结合。
主要发现
- MN(P+)血清或纯化抗PLA2R1 IgG增加PLA2R1 C端片段和可溶性胞外域。
- 该效应可被ADAM10/17抑制剂及可溶性胞外域预孵育阻断,且不依赖补体(热灭活)。
- MN(P+) IgG增强全长PLA2R1脱落但不增强ΔN1-9脱落,PMA则增强两者,提示表位依赖性抗体触发裂解。
- MN(P+) IgG不裂解THSD7A。
- 肾活检中PLA2R1胞外域仅富集于MN(P+)的基底膜沉积物,胞内域各组均局限于足细胞;定量电镜证实MN(P+)中胞外域基底膜偏向分布。
临床怎么用
- 提示抗PLA2R1 IgG通过促进足细胞抗原脱落并锚定于基底膜形成原位免疫复合物。
- 为理解膜性肾病上皮下沉积物的形成机制提供了新视角。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: In membranous nephropathy (MN), subepithelial immune deposits and glomerular basement membrane (GBM) thickening are defining lesions, yet how circulating anti-phospholipase A2 receptor 1 (PLA2R1) IgG generates GBM-anchored complexes from podocyte antigen remains unclear. METHODS: To clarify this, human podocytes stably expressing PLA2R1 and HEK293 cells expressing full-length or antibody-binding-deficient PLA2R1 (ΔN1-9) were stimulated with PLA2R1-positive MN [MN(P+)] serum or purified IgG or the metalloproteinase activator phorbol 12-myristate 13-acetate (PMA). Metalloprotease/γ-secretase dependence was tested with pharmacologic inhibitors; specificity controls included soluble ectodomain (ECD) blockade, IgG depletion, purified anti-PLA2R1 IgG, and THSD7A as unrelated antigen. Kidney biopsies underwent dual immunofluorescence and dual label immunogold electron microscopy. Recombinant ECD binding to collagen IV/laminin was assayed in vitro. RESULTS: MN(P+) serum or purified anti-PLA2R1 IgG increased the PLA2R1 C-terminal fragment and soluble ECD. These effects were blocked by metalloproteinase ADAM10/17 inhibitors and by preincubating IgG/serum with soluble ECD and were complement-independent (heat-inactivation). MN(P+) IgG enhanced shedding of full-length PLA2R1 but not ΔN1-9, whereas PMA increased shedding of both, indicating epitope-dependent, antibody-triggered cleavage. MN(P+) IgG did not cleave THSD7A. In biopsies, PLA2R1-ECD was enriched within GBM deposits in MN(P+) only while PLA2R1-intracellular domain remained podocyte-restricted across groups. Quantitative electron microscopy confirmed GBM-biased ECD distribution in MN(P+). In vitro, PLA2R1-ECD bound collagen IV/laminin and selectively captured MN(P+) IgG. Early MN showed focal GBM thickening at deposit sites. CONCLUSIONS: Anti-PLA2R1 IgG accelerates ADAM10/17-dependent shedding of podocyte PLA2R1 releasing ECD anchors to GBM constituents. This mechanism reconciles the serum antibody glomerular antigen match and the preferential localization of deposits.
引用
- Liu WB, Hu HK, Liu W, et al. Anti-PLA2R1 IgG-mediated podocyte PLA2R1 cleavage drives glomerular subepithelial immune complex deposition in membranous nephropathy. Kidney Int. 2026. PMID: 41833639. doi:10.1016/j.kint.2026.02.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。